Recent studies have shown that MeCP2 specifically promotes the processing of a subset of microRNAs (miRNAs), and miR-199a has been identified as a MeCP2-target miRNA associated with RTT pathophysiology (Tsujimura et al., 2015; Nakashima et al., 2021). The gene discussed is MECP2; the disease is Rett syndrome.